(Q45866510)

17 December 2017

title

Injection of IL-12 gene-transduced dendritic cells into mouse liver tumor lesions activates both innate and acquired immunity (English)

1 reference

17 December 2017

1 reference

11

1 reference

17 December 2017

author name string

Tatsumi T

1

1 reference

17 December 2017

Takehara T

2

1 reference

17 December 2017

Yamaguchi S

3

1 reference

17 December 2017

Sasakawa A

4

1 reference

17 December 2017

Miyagi T

5

1 reference

17 December 2017

Jinushi M

6

1 reference

17 December 2017

Sakamori R

7

1 reference

17 December 2017

Kohga K

8

1 reference

17 December 2017

Uemura A

9

1 reference

17 December 2017

Ohkawa K

10

1 reference

17 December 2017

Hayashi N

12

1 reference

17 December 2017

publication date

8 March 2007

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

14

1 reference

17 December 2017

issue

11

1 reference

17 December 2017

page(s)

863-871

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302941

exact match

0 references

cites work

NK cell compartments and their activation by dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302941

Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302941

7 January 2021

Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302941

7 January 2021

Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302941

7 January 2021

Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302941

7 January 2021

DNA-based immunization by in vivo transfection of dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302941

7 January 2021

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302941

7 January 2021

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302941

7 January 2021

Dendritic cell-based immunotherapy of prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302941

7 January 2021

Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302941

7 January 2021

Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302941

7 January 2021

Dendritic cells are defective in breast cancer patients: a potential role for polyamine in this immunodeficiency

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302941

7 January 2021

Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302941

7 January 2021

Regulation of human cytolytic lymphocyte responses by interleukin-12

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302941

7 January 2021

Interleukin-12 and its role in the generation of TH1 cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302941

7 January 2021

Dendritic cells: a journey from laboratory to clinic

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302941

7 January 2021

IL-12 Acts Directly on DC to Promote Nuclear Localization of NF-κB and Primes DC for IL-12 Production

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302941

7 January 2021

Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302941

7 January 2021

Reciprocal activating interaction between natural killer cells and dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302941

7 January 2021

Overexpression of interleukin-12 enables dendritic cells to activate NK cells and confer systemic antitumor immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302941

7 January 2021

The toxicology of interleukin-12: a review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302941

7 January 2021

Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302941

7 January 2021

Innate and adaptive lymphoid cells in the human liver

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302941

7 January 2021

Immunology of the healthy liver: old questions and new insights

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302941

7 January 2021

CD1d-mediated stimulation of natural killer T cells selectively activates hepatic natural killer cells to eliminate experimentally disseminated hepatoma cells in murine liver

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302941

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3302941

1 reference

17 December 2017

Dimensions Publication ID

0 references

1 reference

17 December 2017